ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Internal Medicine

Top Internal Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SANJAY MADAN MD

Internal Medicine

32,420

$1.03M

1133
1011 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$32
Average prescription price

Avg: $56

STEVEN KANNER DO

Internal Medicine

32,264

$1.12M

1430
1136 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$35
Average prescription price

Avg: $56

UDAY MISHRA MD

Internal Medicine

32,009

$1.66M

864
412 are 65+

48%
patients receiving schedule two controlled substances

Avg: 5%

35%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $56

HUMBERTO HERNANDEZ M.D.

Internal Medicine

31,723

$2.62M

623
552 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

2%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 25%

$82
Average prescription price

Avg: $56

CRISTOBAL ROSARIO M.D.

Internal Medicine

31,422

$1.03M

1107
801 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$33
Average prescription price

Avg: $56

MERCEDES PINO DO

Internal Medicine

31,349

$1.17M

758
704 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$37
Average prescription price

Avg: $56

ASHOK REDDY M.D

Internal Medicine

31,294

$1.25M

1179
779 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$40
Average prescription price

Avg: $56

VORBES ALEGER M.D.

Internal Medicine

31,199

$2.04M

593
458 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

RODERICK NASSIF DO

Internal Medicine

30,877

$1.78M

1103
937 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $56

GARY GOTTHELF MD

Internal Medicine

30,804

$1.94M

1377
1110 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

28%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $56

ZAW MIN MD

Internal Medicine

30,543

$1.58M

1434
895 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $56

ALEX VILLACASTIN M.D.

Internal Medicine

30,461

$2.06M

1714
1297 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $56

JORGE FLEITES M.D.

Internal Medicine

30,391

$1.63M

1094
989 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

2%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $56

PETER CHOY M.D.

Internal Medicine

30,344

$1.64M

1024
975 are 65+

1%
patients receiving schedule two controlled substances

Avg: 5%

2%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $56

ROGELIO ZALDIVAR MD

Internal Medicine

30,257

$1.33M

874
771 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 8%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $56

MIGUEL FANA M.D.

Internal Medicine

30,088

$1.14M

1289
1010 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$38
Average prescription price

Avg: $56

ALI SAIFI MD

Internal Medicine

30,084

$2.17M

1046
807 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $56

LUIS LUGO-ARRENDELL M.D.

Internal Medicine

30,025

$1.3M

1055
952 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

2%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $56

TAHA DIAS MD

Internal Medicine

29,848

$1.63M

1081
656 are 65+

21%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $56

MUHAMMAD KHAN MD

Internal Medicine

29,676

$1.7M

1240
840 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $56

JIRAYOS CHINTANADILOK M.D.

Internal Medicine

29,632

$1.68M

930
644 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $56

DAVID ESCHELBACHER M.D.

Internal Medicine

29,623

$1.62M

475
352 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

35%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $56

GLORIOSA ANTIPORDA M.D.

Internal Medicine

29,586

$1.15M

1408
1022 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

24%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $56

WALTER ZAVALA MD

Internal Medicine

29,537

$999K

1357
1118 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$34
Average prescription price

Avg: $56

JORGE DIAZ D.O.

Internal Medicine

29,524

$1.65M

739
663 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank